Treatment-resistant bipolar depression: A randomized controlled trial of electroconvulsive therapy versus algorithm-based pharmacological treatment

American Journal of Psychiatry

Volumn 172, Issue 1, 2015, Pages 41-51

  Schoeyen, Helle K ^a   Kessler, Ute ^a   Andreassen, Ole A ^a   Auestad, Bjoern H ^a   Bergsholm, Per ^a   Malt, Ulrik F ^a   Morken, Gunnar ^a   Oedegaard, Ketil J ^a   Vaaler, Arne ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALIMEMAZINE; CHLORPROMAZINE; CHLORPROTHIXENE; MIANSERIN; OXAZEPAM; ZOLPIDEM; ZOPICLONE; ANTIDEPRESSANT AGENT;

ADULT; AGED; ALGORITHM; ARTICLE; ASSESSMENT OF HUMANS; BIPOLAR DEPRESSION; CLINICAL GLOBAL IMPRESSIONS SCALE FOR BIPOLAR DISORDER; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; DRUG SAFETY; DRUG THERAPY; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; IATROGENIC DISEASE; INVENTORY OF DEPRESSIVE SYMPTOMATOLOGY CLINICIAN RATED 30 ITEM VERSION; MAJOR CLINICAL STUDY; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT OUTCOME; TREATMENT RESISTANT DEPRESSION; BIPOLAR DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; MIDDLE AGED; NORWAY; PROCEDURES; PSYCHOLOGICAL RATING SCALE;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NORWAY; PSYCHIATRIC STATUS RATING SCALES; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 84920160588     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2014.13111517     Document Type: Article

References (41)

1. Judd LL, Schettler PJ, Akiskal HS, Maser J, Coryell W, Solomon D, Endicott J, Keller M: Long-term symptomatic status of bipolar I vs bipolar II disorders. Int J Neuropsychopharmacol 2003; 6:127-137
2. Suppes T, Kelly DI, Perla JM: Challenges in the management of bipolar depression. J Clin Psychiatry 2005; 66(suppl 5):11-16
3. Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O'Donovan C, Macqueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, Goldstein BI, Lafer B, Birmaher B, Ha K, Nolen WA, Berk M: Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord 2013; 15:1-44
4. Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, Paulsson B, Brecher M; EMBOLDEN I (Trial 001) Investigators: A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry 2010; 71:150-162
5. Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM: Longterm lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 2004; 161:217-222
6. Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A: Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003; 60:1079-1088
7. Finseth PI, Morken G, Andreassen OA, Malt UF, Vaaler AE: Risk factors related to lifetime suicide attempts in acutely admitted bipolar disorder inpatients. Bipolar Disord 2012; 14:727-734
8. Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS, Tondo L, Findling RL, Youngstrom EA, Tohen M, Undurraga J, González-Pinto A, Goldberg JF, Yildiz A, Altshuler LL, Calabrese JR, Mitchell PB, Thase ME, Koukopoulos A, Colom F, Frye MA, Malhi GS, Fountoulakis KN, Vázquez G, Perlis RH, Ketter TA, Cassidy F, Akiskal H, Azorin JM, Valentí M, Mazzei DH, Lafer B, Kato T, Mazzarini L, Martínez-Aran A, Parker G, Souery D, Özerdem A, McElroy SL, Girardi P, Bauer M, Yatham LN, Zarate CA, Nierenberg AA, Birmaher B, Kanba S, El-Mallakh RS, Serretti A, Rihmer Z, Young AH, Kotzalidis GD, MacQueen GM, Bowden CL, Ghaemi SN, Lopez-Jaramillo C, Rybakowski J, Ha K, Perugi G, Kasper S, Amsterdam JD, Hirschfeld RM, Kapczinski F, Vieta E: The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry 2013; 170:1249-1262
9. Goodwin GM; Consensus Group of the British Association for Psychopharmacology: Evidence-based guidelines for treating bipolar disorder: revised second edition-recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2009; 23:346-388
10. Goodwin FK, Jamison JK: Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression, 2nd ed. New York, Oxford University Press, 2007, pp 752-753
11. Malhi GS, Adams D, Lampe L, Paton M, O 'Connor N, Newton LA, Walter G, Taylor A, Porter R, Mulder RT, Berk M; Northern Sydney Central Coast Mental Health Drug & Alcohol; NSW Health Clinical Redesign Program; CADE Clinic, University of Sydney: Clinical practice recommendations for bipolar disorder. Acta Psychiatr Scand Suppl 2009; 439:27-46
12. Nivoli AM, Colom F, Murru A, Pacchiarotti I, Castro-Loli P, González-Pinto A, Fountoulakis KN, Vieta E: New treatment guidelines for acute bipolar depression: a systematic review. J Affect Disord 2011; 129:14-26
13. Fountoulakis KN: Refractoriness in bipolar disorder: definitions and evidence-based treatment. CNS Neurosci Ther 2012; 18:227-237
14. Kellner CH, Greenberg RM, Murrough JW, Bryson EO, Briggs MC, Pasculli RM: ECT in treatment-resistant depression. Am J Psychiatry 2012; 169:1238-1244
15. Sienaert P, Vansteelandt K, Demyttenaere K, Peuskens J: Ultrabrief pulse ECT in bipolar and unipolar depressive disorder: differences in speed of response. Bipolar Disord 2009; 11:418-424
16. Bailine S, Fink M, Knapp R, Petrides G, Husain MM, Rasmussen K, Sampson S, Mueller M, McClintock SM, Tobias KG, Kellner CH: Electroconvulsive therapy is equally effective in unipolar and bipolar depression. Acta Psychiatr Scand 2010; 121:431-436
17. Medda P, Perugi G, Zanello S, Ciuffa M, Rizzato S, Cassano GB: Comparative response to electroconvulsive therapy in medication-resistant bipolar I patients with depression and mixed state. J ECT 2010; 26:82-86
18. Dierckx B, Heijnen WT, van den Broek WW, Birkenhäger TK: Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta-analysis. Bipolar Disord 2012; 14:146-150
19. Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382-389
20. Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger J, Burns C: The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res 1986; 18:65-87
21. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W: Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997; 73:159-171
22. Kessler U, Vaaler AE, Schoyen H, Oedegaard KJ, Bergsholm P, Andreassen OA, Malt UF, Morken G: The study protocol of the Norwegian randomized controlled trial of electroconvulsive therapy in treatment resistant depression in bipolar disorder. BMC Psychiatry 2010; 10:16
23. First M, Spitzer R, Gibbon M, Williams J: Structured Interview for the Diagnostic and Statistical Manual of Mental Disorders, Patient Version, 4th ed. Washington, DC, American Psychiatric Press, 1997
24. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th ed. Washington, DC, APA, 1994
25. Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435
26. d'Elia G: Unilateral electroconvulsive therapy. Acta Psychiatr Scand Suppl 1970; 215:1-98
27. Abrams R: Electroconvulsive Therapy. New York, Oxford University Press, 2002, p 4
28. American Psychiatric Association: The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging: A Task Force Report of the American Psychiatric Association, 2nd ed. Washington, DC, APA, 2001
29. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59(suppl 20):22-33
30. Post RM, Nolen WA, Kupka RW, Denicoff KD, Leverich GS, Keck PE Jr, McElroy SL, Rush AJ, Suppes T, Altshuler LL, Frye MA, Grunze H, Walden J: The Stanley Foundation Bipolar Network, I: rationale and methods. Br J Psychiatry Suppl 2001; 41:s169-s176
31. Morken G, Vaaler AE, Folden GE, Andreassen OA, Malt UF: Age at onset of first episode and time to treatment in in-patients with bipolar disorder. Br J Psychiatry 2009; 194:559-560
32. R Core Team: R: A Language and Environment for Statistical Computing. Vienna, R Foundation for Statistical Computing, 2012 (http://www.r-project.org/)
33. Gueorguieva R, Krystal JH: Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry 2004; 61:310-317
34. Lingjærde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K: The UKU side effect rating scale: a new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 1987; 334: 1-100
35. UK ECT Review Group: Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003; 361:799-808
36. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
37. Heijnen WT, Birkenhäger TK, Wierdsma AI, van den Broek WW: Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis. J Clin Psychopharmacol 2010; 30:616-619
38. Folkerts HW, Michael N, Tölle R, Schonauer K, Mücke S, Schulze-Mönking H: Electroconvulsive therapy vs paroxetine in treatmentresistant depression - a randomized study. Acta Psychiatr Scand 1997; 96:334-342
39. Kellner CH, Knapp R, Husain MM, Rasmussen K, Sampson S, Cullum M, McClintock SM, Tobias KG, Martino C, Mueller M, Bailine SH, Fink M, Petrides G: Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry 2010; 196:226-234
40. Judd LL, Akiskal HS, Schettler PJ, Coryell W, Maser J, Rice JA, Solomon DA, Keller MB: The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders? J Affect Disord 2003; 73: 19-32
41. Baldessarini R, Henk H, Sklar A, Chang J, Leahy L: Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence. Psychiatr Serv 2008; 59:1175-1183